SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-17-001715
Filing Date
2017-02-17
Accepted
2017-02-16 18:51:01
Documents
5
Effectiveness Date
2017-02-17

Document Format Files

Seq Description Document Type Size
1 S-8 (FY2016) rare-s8.htm S-8 87729
2 EX-5.1 rare-ex51_7.htm EX-5.1 10728
3 EX-23.1 rare-ex231_6.htm EX-23.1 2642
4 GRAPHIC g2017021621335031717860.jpg GRAPHIC 4841
5 GRAPHIC g2017021621335038217861.jpg GRAPHIC 20102
  Complete submission text file 0001564590-17-001715.txt   136744
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-216110 | Film No.: 17619331
SIC: 2834 Pharmaceutical Preparations